Nasal High-Flow Therapy: Role of FiO2 in the ROX Index
- PMID: 30896967
- PMCID: PMC6603067
- DOI: 10.1164/rccm.201902-0376LE
Nasal High-Flow Therapy: Role of FiO2 in the ROX Index
Figures

Comment in
-
Reply to Tatkov, to Karim and Esquinas, and to Tulaimat.Am J Respir Crit Care Med. 2019 Jul 1;200(1):117-119. doi: 10.1164/rccm.201903-0571LE. Am J Respir Crit Care Med. 2019. PMID: 30896963 Free PMC article. No abstract available.
Comment on
-
An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy.Am J Respir Crit Care Med. 2019 Jun 1;199(11):1368-1376. doi: 10.1164/rccm.201803-0589OC. Am J Respir Crit Care Med. 2019. PMID: 30576221
References
-
- Roca O, Caralt B, Messika J, Samper M, Sztrymf B, Hernández G, et al. An index combining respiratory rate and oxygenation to predict outcome of nasal high flow therapy. Am J Respir Crit Care Med. [online ahead of print] 21 Dec 2018; DOI: 10.1164/rccm.201803-0589OC. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical